TY  - BOOK
AU  - Yerasi, Charan
TI  - Endoscopic versus Percutaneous Biliary Drainage in Palliation of Advanced Malignant Hilar Obstruction: A Meta-Analysis and Systematic Review. [Review]
SN  - 2291-2789
PY  - 2016///
KW  - *Cholestasis/su [Surgery]
KW  - *Drainage/mt [Methods]
KW  - *Endoscopy/mt [Methods]
KW  - *Palliative Care/mt [Methods]
KW  - Adult
KW  - Bile Duct Neoplasms/co [Complications]
KW  - Bile Duct Neoplasms/pa [Pathology]
KW  - Cholestasis/et [Etiology]
KW  - Female
KW  - Humans
KW  - Klatskin Tumor/co [Complications]
KW  - Klatskin Tumor/pa [Pathology]
KW  - Male
KW  - Middle Aged
KW  - Odds Ratio
KW  - MedStar Washington Hospital Center
KW  - Medicine/General Internal Medicine
KW  - Journal Article
KW  - Review
N2  - Background. Palliation in advanced unresectable hilar malignancies can be achieved by endoscopic (EBD) or percutaneous transhepatic biliary drainage (PTBD). It is unclear if one approach is superior to the other in this group of patients. Aims. Compare clinical outcomes of EBD versus PTBD. Methods. (i) Study Selection Criterion. Studies using PTBD and EBD for palliation of advanced unresectable hilar malignancies. (ii) Data Collection and Extraction. Articles were searched in Medline, PubMed, and Ovid journals. (iii) Statistical Method. Fixed and random effects models were used to calculate the pooled proportions. Results. Initial search identified 786 reference articles, in which 62 articles were selected and reviewed. Data was extracted from nine studies (N = 546) that met the inclusion criterion. The pooled odds ratio for successful biliary drainage in PTBD versus EBD was 2.53 (95% CI = 1.57 to 4.08). Odds ratio for overall adverse effects in PTBD versus EBD groups was 0.81 (95% CI = 0.52 to 1.26). Odds ratio for 30-day mortality rate in PTBD group versus EBD group was 0.84 (95% CI = 0.37 to 1.91). Conclusions. In patients with advanced unresectable hilar malignancies, palliation with PTBD seems to be superior to EBD. PTBD is comparable to EBD in regard to overall adverse effects and 30-day mortality
ER  -